ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.12	13.29	12.6	5.88	16.94
Short-Term Investments	0.03	0.03	0.03	0.04	0.04
Cash & Short-Term Investments	6.15	13.32	12.63	5.92	16.98
Cash Growth	-53.84%	5.49%	113.36%	-65.14%	1857.25%
Other Receivables	0.04	0.08	0.08	0.07	0.05
Receivables	0.04	0.08	0.08	0.07	0.05
Prepaid Expenses	0.3	0.37	0.53	0.56	0.12
Other Current Assets	2.7	5.13	0.38	0.35	0.56
Total Current Assets	9.18	18.91	13.62	6.9	17.71
Property, Plant & Equipment	-	-	-	0	0
Other Intangible Assets	-	-	-	0.02	0.03
Total Assets	9.18	18.91	13.62	6.92	17.75
Accounts Payable	2.54	1.74	7.84	2.98	0.41
Accrued Expenses	7.87	0.48	1.51	3.44	0.52
Total Current Liabilities	10.41	2.22	9.35	6.41	0.93
Long-Term Debt	-	-	-	-	3.91
Other Long-Term Liabilities	0.03	0.2	0.52	1.86	7.25
Total Liabilities	10.44	2.42	9.87	8.27	12.09
Additional Paid-In Capital	129.52	107.55	97.59	79.1	68.04
Retained Earnings	-130.41	-90.69	-93.47	-80.25	-62.19
Comprehensive Income & Other	-0.37	-0.37	-0.37	-0.2	-0.19
Shareholders' Equity	-1.26	16.49	3.75	-1.35	5.66
Total Liabilities & Equity	9.18	18.91	13.62	6.92	17.75
Total Debt	-	-	-	-	3.91
Net Cash (Debt)	6.15	13.32	12.63	5.92	13.08
Net Cash Growth	-53.84%	5.49%	113.36%	-54.73%	1407.11%
Net Cash Per Share	3.50	12.59	25.69	19.73	56.51
Filing Date Shares Outstanding	8.97	1.31	0.76	0.34	0.29
Total Common Shares Outstanding	2.15	1.31	0.76	0.34	0.29
Working Capital	-1.23	16.69	4.27	0.49	16.79
Book Value Per Share	-0.58	12.61	4.97	-3.93	19.67
Tangible Book Value	-1.26	16.49	3.75	-1.37	5.63
Tangible Book Value Per Share	-0.58	12.61	4.97	-3.99	19.57
Machinery	-	-	-	-	0.08

Updated Mar 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q